What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Toxoplasmosis in Cats: Perinatal Transmission and Public Health Concerns

Etiology and Life Cycle of Toxoplasma gondii

Toxoplasmosis is caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii. The definitive host is the domestic cat and other felids, in which the sexual phase of the life cycle occurs within the intestinal epithelium, leading to the shedding of environmentally resistant oocysts [1]. Intermediate hosts, including mammals and birds, harbor the asexual stages: tachyzoites (rapidly dividing forms) and bradyzoites (slowly dividing forms contained within tissue cysts) [2]. The life cycle is complex, involving three principal infectious stages: sporozoites (within sporulated oocysts), tachyzoites, and bradyzoites [3]. Cats become infected by ingesting tissue cysts from intermediate hosts (e.g., rodents, birds) or, less commonly, by ingesting sporulated oocysts from the environment [4]. Following ingestion, bradyzoites are released in the stomach and small intestine, invade the intestinal mucosa, and undergo schizogony and gametogony, culminating in the formation of unsporulated oocysts that are shed in feces [5]. The prepatent period is typically 3 to 10 days after ingestion of tissue cysts but can be longer (18 days or more) after oocyst ingestion [6]. Shedding of oocysts usually lasts 1 to 3 weeks, during which millions of oocysts can be excreted daily [7]. Once shed, oocysts sporulate in the environment within 1 to 5 days, becoming infective [8]. Sporulated oocysts are remarkably resilient, surviving for months to years in moist soil, water, and other environmental matrices [9].

Epidemiology of Feline Toxoplasmosis

Seroprevalence of T. gondii in domestic cat populations varies widely based on geographic location, age, diet, and lifestyle. Studies report seroprevalence rates ranging from 20% to 80% in various global regions [10]. Outdoor cats that hunt have a significantly higher risk of infection compared to strictly indoor cats [11]. The prevalence of oocyst shedding in feces is generally low (less than 1% to 5%) at any given time, as shedding is typically transient and occurs primarily after primary infection [12]. Re-shedding of oocysts can occur upon reinfection or immunosuppression, but this is considered rare [13]. The epidemiology of feline toxoplasmosis is directly linked to the ecology of local intermediate host populations and environmental contamination with oocysts [14].

Perinatal Transmission in Cats

Perinatal (vertical) transmission of T. gondii in cats occurs when a pregnant queen acquires a primary infection during gestation [15]. The mechanism involves transplacental passage of tachyzoites from the maternal circulation to the developing fetus [16]. Tachyzoites cross the placental barrier and infect fetal tissues, leading to a spectrum of outcomes depending on the stage of gestation at the time of infection [17]. Infection early in gestation can result in fetal resorption, abortion, or stillbirth [18]. Infection later in gestation may lead to the birth of live kittens with subclinical or clinical toxoplasmosis [19]. Clinical signs in congenitally infected kittens can include fever, lethargy, dyspnea, icterus, neurological deficits (e.g., ataxia, seizures, tremors), and ocular lesions (e.g., uveitis, chorioretinitis) [20]. The severity of disease is often more pronounced in kittens infected in utero compared to those infected postnatally [21]. It is important to note that vertical transmission in cats is considered less common than in some other species (e.g., sheep, humans) but remains a significant cause of neonatal morbidity and mortality in feline medicine [22]. The risk of vertical transmission is highest when a seronegative queen is exposed to T. gondii for the first time during pregnancy [23].

Clinical Signs and Pathology in Cats

Most immunocompetent adult cats infected with T. gondii remain asymptomatic [24]. When clinical disease occurs, it is most frequently associated with the pulmonary, hepatic, nervous, and ocular systems [25]. The most commonly reported clinical signs include fever, anorexia, lethargy, and dyspnea [26]. Respiratory signs result from interstitial pneumonia caused by tachyzoite proliferation in alveolar macrophages and pneumocytes [27]. Hepatic involvement can lead to icterus and elevated liver enzyme activities [28]. Neurological signs, such as ataxia, circling, head pressing, seizures, and behavioral changes, are attributable to meningoencephalitis and focal necrosis in the brain [29]. Ocular disease, particularly anterior uveitis, is a common manifestation in cats and may be the sole presenting sign [30]. Chorioretinitis and optic neuritis are also documented [31]. Pathological findings at necropsy include multifocal necrosis in the liver, lungs, pancreas, and lymph nodes, with associated inflammation [32]. Tissue cysts are most commonly found in the brain, skeletal muscle, and myocardium [33].

Diagnostic Approaches

Diagnosis of feline toxoplasmosis relies on a combination of serology, molecular techniques, cytology, histopathology, and bioassay [34].

Serology: Detection of anti-T. gondii immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies is the most common diagnostic approach [35]. A positive IgG titer indicates prior exposure and is not diagnostic of active disease [36]. A four-fold rise in IgG titer over a 2 to 4 week period, or the presence of IgM antibodies, suggests recent or active infection [37]. Commercial enzyme-linked immunosorbent assays (ELISAs) and indirect immunofluorescence assays (IFATs) are widely used [38]. The modified agglutination test (MAT) is considered a reference standard for seroprevalence studies [39].

Molecular Diagnostics: Polymerase chain reaction (PCR) assays targeting the B1 gene or the 529 bp repetitive element are highly sensitive and specific for detecting T. gondii DNA in blood, aqueous humor, cerebrospinal fluid (CSF), bronchoalveolar lavage fluid, and tissue biopsies [40]. Real-time quantitative PCR (qPCR) allows for quantification of parasite burden [41].

Cytology and Histopathology: Tachyzoites can be identified in cytological preparations of CSF, tracheal wash fluid, or fine-needle aspirates of lymph nodes or organs [42]. Tissue cysts and tachyzoites are detectable in histopathological sections stained with hematoxylin and eosin or by immunohistochemistry [43].

Bioassay: Mouse or cat bioassays are highly sensitive for detecting infectious T. gondii in tissues or feces but are rarely used in clinical practice due to ethical and logistical constraints [44].

Fecal Examination: Detection of oocysts in feces is performed by centrifugal flotation using Sheather's sugar solution or zinc sulfate [45]. However, oocysts are morphologically indistinguishable from those of Hammondia hammondi and Besnoitia spp., requiring molecular confirmation or bioassay for definitive identification [46].

Diagnostic Decision Tree

flowchart TD
    A[Clinical suspicion of toxoplasmosis], > B{Serology: IgM & IgG}
    B, >|IgG positive, IgM negative| C[Past exposure; active disease unlikely]
    B, >|IgG positive, IgM positive| D[Recent or active infection]
    B, >|IgG negative, IgM negative| E[No evidence of infection]
    D, > F{Confirm with PCR on blood, CSF, or aqueous humor}
    F, >|PCR positive| G[Definitive diagnosis of active toxoplasmosis]
    F, >|PCR negative| H[Consider other differentials; repeat serology in 2-4 weeks]
    G, > I[Initiate antiprotozoal therapy]
    I, > J[Monitor clinical response and serology]

Treatment and Clinical Management

Treatment is indicated for cats with clinical toxoplasmosis, particularly those with ocular, neurological, or respiratory signs [47]. The standard therapeutic regimen consists of clindamycin hydrochloride administered orally or parenterally at a dosage of 10 to 12 mg/kg every 12 hours for 4 weeks [48]. Alternative therapies include trimethoprim-sulfonamide combinations (15 mg/kg every 12 hours) or pyrimethamine (0.5 to 1 mg/kg every 24 hours) in combination with a sulfonamide [49]. Adjunctive therapy with corticosteroids (e.g., prednisolone at 1 to 2 mg/kg every 12 to 24 hours) is indicated for ocular toxoplasmosis to control inflammation and prevent secondary glaucoma [50]. Supportive care, including fluid therapy, nutritional support, and management of secondary infections, is critical in severe cases [51]. Treatment of pregnant queens is challenging, as clindamycin does not reliably cross the placenta in sufficient concentrations to prevent fetal infection [52]. Prevention of primary infection in breeding queens is the most effective strategy to avoid perinatal transmission [53].

Public Health Concerns: Cat Toxoplasmosis Baby Risk

The primary public health concern associated with feline toxoplasmosis is the zoonotic transmission of T. gondii to humans, particularly to pregnant women and immunocompromised individuals [54]. The term "cat toxoplasmosis baby" refers to the risk of congenital toxoplasmosis in infants born to women who acquire a primary infection during pregnancy [55]. Congenital transmission in humans occurs when tachyzoites cross the placenta and infect the fetus, potentially leading to miscarriage, stillbirth, or severe neonatal disease including chorioretinitis, hydrocephalus, and intracranial calcifications [56]. The risk of fetal infection increases with gestational age, while the severity of disease decreases [57]. Cats are not directly contagious to humans through casual contact; transmission occurs primarily through the accidental ingestion of sporulated oocysts from contaminated environments (e.g., litter boxes, soil, gardening) or through consumption of undercooked meat containing tissue cysts [58]. Pregnant women and immunocompromised individuals are advised to avoid cleaning litter boxes, or to use gloves and wash hands thoroughly if this is unavoidable [59]. Litter boxes should be cleaned daily, as oocysts require at least 24 to 48 hours to sporulate and become infective [60]. Indoor cats that do not hunt and are fed commercial cooked or canned diets pose a negligible risk of shedding T. gondii oocysts [61]. For a more detailed discussion of zoonotic risks, readers are directed to the article on Toxoplasmosis in Cats: Zoonotic Transmission and Public Health Concerns. Additional information on risks during pregnancy is available in Toxoplasmosis in Cats: Risks During Pregnancy and Prevention.

Control and Prevention Strategies

Control of toxoplasmosis in cats and reduction of zoonotic risk require a multi-faceted approach [62]. Key strategies include:

Dietary Management: Feeding cats only commercial cooked or canned food to prevent ingestion of tissue cysts from raw meat or intermediate hosts [63].
Environmental Hygiene: Daily removal of feces from litter boxes to prevent oocyst sporulation [64]. Litter boxes should be disinfected with hot water (above 70 degrees Celsius) or steam, as oocysts are resistant to most common disinfectants [65].
Preventing Hunting: Keeping cats indoors to reduce exposure to infected prey [66].
Rodent Control: Implementing integrated pest management to reduce the availability of infected rodents [67].
Pregnant Cat Management: Isolating pregnant queens from potential sources of infection and maintaining strict hygiene protocols [68].
Public Education: Informing cat owners, particularly pregnant women, about the routes of transmission and preventive measures [69].

Conclusion

Toxoplasmosis in cats remains a significant veterinary and public health concern due to the parasite's complex life cycle, potential for perinatal transmission, and zoonotic implications. Accurate diagnosis relies on a combination of serological and molecular methods. Treatment with clindamycin is effective for clinical cases, but prevention through management practices is paramount. The risk of congenital toxoplasmosis in humans, often colloquially referred to as "cat toxoplasmosis baby," can be effectively minimized through simple hygiene measures and responsible pet ownership. Continued research into diagnostic tools, therapeutic agents, and preventive strategies is essential for managing this ubiquitous parasite.

References

[1] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[2] Dubey, J.P., & Beattie, C.P. (1988). Toxoplasmosis of Animals and Man. CRC Press.

[3] Frenkel, J.K. (1973). Toxoplasmosis: parasite life cycle, pathology, and immunology. In: Hammond, D.M., & Long, P.L. (Eds.), The Coccidia. University Park Press.

[4] Dubey, J.P. (1996). Infectivity and pathogenicity of Toxoplasma gondii oocysts for cats. Journal of Parasitology, 82(6), 957-961.

[5] Dubey, J.P., & Frenkel, J.K. (1972). Cyst-induced toxoplasmosis in cats. Journal of Protozoology, 19(1), 155-177.

[6] Dubey, J.P. (2001). Oocyst shedding by cats fed isolated bradyzoites and comparison of infectivity of bradyzoites of the VEG strain Toxoplasma gondii to cats and mice. Journal of Parasitology, 87(1), 215-219.

[7] Dubey, J.P. (1995). Duration of immunity to shedding of Toxoplasma gondii oocysts by cats. Journal of Parasitology, 81(3), 410-415.

[8] Dubey, J.P. (1998). Toxoplasma gondii oocyst survival under defined temperatures. Journal of Parasitology, 84(4), 862-865.

[9] Lindsay, D.S., & Dubey, J.P. (2009). Long-term survival of Toxoplasma gondii sporulated oocysts in seawater. Journal of Parasitology, 95(4), 1019-1020.

[10] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[11] Vollaire, M.R., Radecki, S.V., & Lappin, M.R. (2005). Seroprevalence of Toxoplasma gondii antibodies in cats from the United States. Journal of the American Veterinary Medical Association, 226(6), 874-877.

[12] Dabritz, H.A., & Conrad, P.A. (2010). Cats and Toxoplasma: implications for public health. Zoonoses and Public Health, 57(1), 34-52.

[13] Dubey, J.P. (1995). Duration of immunity to shedding of Toxoplasma gondii oocysts by cats. Journal of Parasitology, 81(3), 410-415.

[14] Afonso, E., Thulliez, P., & Gilot-Fromont, E. (2006). Transmission of Toxoplasma gondii in an urban population of domestic cats (Felis catus). International Journal for Parasitology, 36(13), 1373-1382.

[15] Dubey, J.P., & Carpenter, J.L. (1993). Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association, 203(11), 1556-1566.

[16] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[17] Dubey, J.P., & Frenkel, J.K. (1972). Cyst-induced toxoplasmosis in cats. Journal of Protozoology, 19(1), 155-177.

[18] Dubey, J.P., & Carpenter, J.L. (1993). Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association, 203(11), 1556-1566.

[19] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[20] Lappin, M.R. (2010). Toxoplasmosis. In: Greene, C.E. (Ed.), Infectious Diseases of the Dog and Cat (4th ed.). Saunders Elsevier.

[21] Dubey, J.P., & Carpenter, J.L. (1993). Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association, 203(11), 1556-1566.

[22] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[23] Dubey, J.P., & Frenkel, J.K. (1972). Cyst-induced toxoplasmosis in cats. Journal of Protozoology, 19(1), 155-177.

[24] Dubey, J.P., & Carpenter, J.L. (1993). Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association, 203(11), 1556-1566.

[25] Lappin, M.R. (2010). Toxoplasmosis. In: Greene, C.E. (Ed.), Infectious Diseases of the Dog and Cat (4th ed.). Saunders Elsevier.

[26] Dubey, J.P., & Carpenter, J.L. (1993). Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association, 203(11), 1556-1566.

[27] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[28] Lappin, M.R. (2010). Toxoplasmosis. In: Greene, C.E. (Ed.), Infectious Diseases of the Dog and Cat (4th ed.). Saunders Elsevier.

[29] Dubey, J.P., & Carpenter, J.L. (1993). Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association, 203(11), 1556-1566.

[30] Lappin, M.R. (2010). Toxoplasmosis. In: Greene, C.E. (Ed.), Infectious Diseases of the Dog and Cat (4th ed.). Saunders Elsevier.

[31] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[32] Dubey, J.P., & Carpenter, J.L. (1993). Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association, 203(11), 1556-1566.

[33] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[34] Lappin, M.R. (2010). Toxoplasmosis. In: Greene, C.E. (Ed.), Infectious Diseases of the Dog and Cat (4th ed.). Saunders Elsevier.

[35] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[36] Lappin, M.R. (2010). Toxoplasmosis. In: Greene, C.E. (Ed.), Infectious Diseases of the Dog and Cat (4th ed.). Saunders Elsevier.

[37] Dubey, J.P., & Carpenter, J.L. (1993). Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association, 203(11), 1556-1566.

[38] Lappin, M.R. (2010). Toxoplasmosis. In: Greene, C.E. (Ed.), Infectious Diseases of the Dog and Cat (4th ed.). Saunders Elsevier.

[39] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[40] Lappin, M.R. (2010). Toxoplasmosis. In: Greene, C.E. (Ed.), Infectious Diseases of the Dog and Cat (4th ed.). Saunders Elsevier.

[41] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[42] Lappin, M.R. (2010). Toxoplasmosis. In: Greene, C.E. (Ed.), Infectious Diseases of the Dog and Cat (4th ed.). Saunders Elsevier.

[43] Dubey, J.P., & Carpenter, J.L. (1993). Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association, 203(11), 1556-1566.

[44] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[45] Lappin, M.R. (2010). Toxoplasmosis. In: Greene, C.E. (Ed.), Infectious Diseases of the Dog and Cat (4th ed.). Saunders Elsevier.

[46] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[47] Lappin, M.R. (2010). Toxoplasmosis. In: Greene, C.E. (Ed.), Infectious Diseases of the Dog and Cat (4th ed.). Saunders Elsevier.

[48] Dubey, J.P., & Carpenter, J.L. (1993). Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association, 203(11), 1556-1566.

[49] Lappin, M.R. (2010). Toxoplasmosis. In: Greene, C.E. (Ed.), Infectious Diseases of the Dog and Cat (4th ed.). Saunders Elsevier.

[50] Lappin, M.R. (2010). Toxoplasmosis. In: Greene, C.E. (Ed.), Infectious Diseases of the Dog and Cat (4th ed.). Saunders Elsevier.

[51] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[52] Dubey, J.P., & Frenkel, J.K. (1972). Cyst-induced toxoplasmosis in cats. Journal of Protozoology, 19(1), 155-177.

[53] Lappin, M.R. (2010). Toxoplasmosis. In: Greene, C.E. (Ed.), Infectious Diseases of the Dog and Cat (4th ed.). Saunders Elsevier.

[54] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[55] Dubey, J.P., & Beattie, C.P. (1988). Toxoplasmosis of Animals and Man. CRC Press.

[56] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[57] Dubey, J.P., & Beattie, C.P. (1988). Toxoplasmosis of Animals and Man. CRC Press.

[58] Dabritz, H.A., & Conrad, P.A. (2010). Cats and Toxoplasma: implications for public health. Zoonoses and Public Health, 57(1), 34-52.

[59] Lappin, M.R. (2010). Toxoplasmosis. In: Greene, C.E. (Ed.), Infectious Diseases of the Dog and Cat (4th ed.). Saunders Elsevier.

[60] Dubey, J.P. (1998). Toxoplasma gondii oocyst survival under defined temperatures. Journal of Parasitology, 84(4), 862-865.

[61] Vollaire, M.R., Radecki, S.V., & Lappin, M.R. (2005). Seroprevalence of Toxoplasma gondii antibodies in cats from the United States. Journal of the American Veterinary Medical Association, 226(6), 874-877.

[62] Dabritz, H.A., & Conrad, P.A. (2010). Cats and Toxoplasma: implications for public health. Zoonoses and Public Health, 57(1), 34-52.

[63] Dubey, J.P. (2010). Toxoplasmosis of Animals and Humans. CRC Press.

[64] Lappin, M.R. (2010). Toxoplasmosis. In: Greene, C.E. (Ed.), Infectious Diseases of the Dog and Cat (4th ed.). Saunders Elsevier.

[65] Dubey, J.P. (1998). Toxoplasma gondii oocyst survival under defined temperatures. Journal of Parasitology, 84(4), 862-865.

[66] Vollaire, M.R., Radecki, S.V., & Lappin, M.R. (2005). Seroprevalence of Toxoplasma gondii antibodies in cats from the United States. Journal of the American Veterinary Medical Association, 226(6), 874-877.

[67] Afonso, E., Thulliez, P., & Gilot-Fromont, E. (2006). Transmission of Toxoplasma gondii in an urban population of domestic cats (Felis catus). International Journal for Parasitology, 36(13), 1373-1382.

[68] Dubey, J.P., & Frenkel, J.K. (1972). Cyst-induced toxoplasmosis in cats. Journal of Protozoology, 19(1), 155-177.

[69] Dabritz, H.A., & Conrad, P.A. (2010). Cats and Toxoplasma: implications for public health. Zoonoses and Public Health, 57(1), 34-52. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.